Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065228 · ClinicalTrials.gov registry record
Therapeutic Endpoint in Pediatric IBD Conditions
A clinical trial of Crohn Disease and Inflammatory Bowel Diseases, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06065228 is a study of Crohn Disease and Inflammatory Bowel Diseases that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 60 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06065228, a study of Crohn Disease and Inflammatory Bowel Diseases, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.
Conditions Studied
Interventions
- OTHER AlgometRx Nociometer
Study Locations (1)
District of Columbia
- Children's National Health System - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06065228
The ClinicalTrials.gov registry entry for NCT06065228 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (71% lower). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Crohn Disease appearing as the primary indexed condition, and to 1 intervention - of which AlgometRx Nociometer is the first listed.
NCT06065228 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06065228 about?
NCT06065228 is a clinical study titled "Therapeutic Endpoint in Pediatric IBD Conditions". The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory respon...
What is the current status of trial NCT06065228?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2023-11-27. Estimated completion is 2025-12.
What conditions does trial NCT06065228 study?
This clinical trial studies the following conditions: Crohn Disease, Inflammatory Bowel Diseases, Colitis, Ulcerative.
What interventions are being tested in trial NCT06065228?
The interventions under investigation include: AlgometRx Nociometer (OTHER).
Who is sponsoring clinical trial NCT06065228?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06065228 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Low Dose IL-2 for the Treatment of Crohn's Disease
RECRUITING · Phase 1
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
RECRUITING · Phase 4
Explore more on PlainTrial
Crohn Disease
All registered trials for this condition
Inflammatory Bowel Diseases
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.